Course Overview

 Why choose this programme

The primary objective of this course is to provide formal training in cellular bioprocessing for clinical application for those who wish to study key emerging technologies for medical intervention. The course is designed according to Good Manufacturing Practices and provides a rigorous scientific underpinning for the development of a cellular therapy. 

Cellular manufacturing and therapy and the production of advanced medicinal products (ATMPs), is quickly evolving as the future of medicine.

With the support and expertise located within the Centre for Cell Manufacturing Ireland, the Clinical Research Facility, the Translational Research Facility, the Regenerative Medicine Institute and the Galway Blood and Tissue Establishment, our students will have access to an internationally competitive MSc programme in Cellular Manufacturing and Therapy.

Richa Krishna Poster Day

Richa Krishna, MSc student, Cellular Manufacturing & Therapy, pictured at Poster Day.

Unique position

This programme is uniquely positioned at NUI Galway to draw on existing expertise in science education, biomedical research, Good Manufacturing Practice (GMP)-grade cellular manufacturing and clinical translation of advanced therapeutics to educate future leaders in these emerging technologies. With the support and expertise located within the Centre for Cell Manufacturing Ireland, the Clinical Research Facility, the Translational Research Facility, the Regenerative Medicine Institute and the Galway Blood and Tissue Establishment, our students will have access to an internationally competitive MSc programme in Cellular Manufacturing and Therapy.  

New skills

 Upon successful completion of the course, you will have had the opportunity to master the following skillsets:

Technical skills

 Aseptic technique in mammalian cell culture

  • Thawing cryopreserved cells
  • Plating and expanding adherent and non-adherent mammalian cells
  • Passaging cells
  • Quantifying cell number, viability, density
  • Cryopreserving cells
  • Utilization of a haemocytometer
  • Pipetting large and small volumes
  • Sterile gowning
  • Data collection, presentation and analysis
  • Technical writing 

Transferable skills

  •  Ability to meet deadlines
  • Adaptability and flexibility
  • Administrative skills
  • Analysis and decision making
  • Critical thinking and evaluation of published literature
  • Ethics & Social understanding underpinning cellular therapy
  • Research/scientific integrity
  • Interpersonal skills
  • Team leadership
  • Motivation to achieve
  • Networking
  • Organizational skills
  • Personal effectiveness
  • Problem solving
  • Public speaking
  • Time management
  • Willingness to learn
  • Written communication

Allied NUI Galway course  

  •  Microscopy and imaging of cells and tissue samples is a highly desirable skill for academia and industry alike.  Click here to learn more. 

Applications and Selections

Who Teaches this Course

Janusz Krawczyk
Consultant Haematologist and Senior Lecturer

Cynthia Coleman
Research Fellow in Orthobiologics and Lecturer

Andrew Finnerty
General Manager of Centre for Cell Manufacturing Ireland

Sanbing Shen
Professor of Fundamental Stem Cell Biology

Timothy O’Brien
Professor of Medicine, Consultant Physician in Endocrinology and Director of Regenerative Medicine Institute

Linda Howard
Lecturer in Regenerative Medicine

Aoife Duffy
Production  Manager in Centre for Cell Manufacturing  Ireland

Mary Murphy
Senior Lecturer in Regenerative Medicine

Matt Griffin
Professor of Transplant Biology

Aideen Ryan
Research Fellow and Lecturer

Roisin Dwyer
Lecturer in Translational Medicine

Requirements and Assessment

Key Facts

Entry Requirements

Students must have completed one of the following ;
1) An undergraduate degree in medicine, pharmacy, manufacturing, biology, engineering.
2) An equivalent biomedical science-related undergraduate degree with a minimum of 2nd Class Honours. 

Applicants from non-biomedical science related backgrounds will be considered on a case-by-case basis at the discretion of the coordinators.  Students who have a degree without Honours in a related area and have 3+ years of practical experience in the subject area will also be considered for this programme. 

 For applicants where English is a second language, we will adhere to NUI Galway guidelines of requiring IELTS scores of 6.5, TOEFL scores of 88 and/or Pearson PTE scores of 61 with no less than 6.5 in any component.

 Initially a short listing procedure will be applied to prioritize applicants.  Those who do not meet the primary entry criteria as described above will be declined entry into the programme.  The remaining applicants will be reviewed in closer detail.  Significant weight will be placed on A) the applicant’s essay describing their motivation for applying for this course and their career aspirations following the successful completion of the MSc, B) the applicant’s referee’s comments and C) the applicant’s previous academic performance.  An interview may be conducted.


Additional Requirements

Duration

1 year full-time

Next start date

September 2018

A Level Grades ()

Average intake

15-18

Closing Date

Please refer to the review/closing date website.

Next start date

September 2018

NFQ level

Mode of study

ECTS weighting

90 ECTS

Award

CAO

PAC code

GYM80

Course Outline

This is a one year full time course consisting of 90 ECTS.

CC Course Outline

Semester 1 (30 ECTS)
Core modules (20ECTS) in Cellular Manufacturing I, and Immune Cell Therapy as well as an elective module (10 ECTS) in Project Management, Molecular & Cellular Biology of Cancer, Economic Evaluation of Health Care, Introduction to Business or Fundamental Concepts in Pharmacology.

Semester 2 (30ECTS)
Compulsory modules in Cellular Manufacturing II, Mesenchymal Stem Cell Therapy and Induced Pluripotent Stem Cell Therapy.  These modules have both class room and laboratory based components.

Semester 3 (30 ECTS)
Compulsory dissertation to be completed by independent study.  This will consist of a literature review on cellular therapy, advanced cellular manufacturing (or comparable area) for publication in a relevant high-impact journal.

Curriculum Information

Curriculum information relates to the current academic year (in most cases).
Course and module offerings and details may be subject to change.

Glossary of Terms

Credits
You must earn a defined number of credits (aka ECTS) to complete each year of your course. You do this by taking all of its required modules as well as the correct number of optional modules to obtain that year's total number of credits.
Module
An examinable portion of a subject or course, for which you attend lectures and/or tutorials and carry out assignments. E.g. Algebra and Calculus could be modules within the subject Mathematics. Each module has a unique module code eg. MA140.
Optional
A module you may choose to study.
Required
A module that you must study if you choose this course (or subject).
Semester
Most courses have 2 semesters (aka terms) per year.

Year 1 (90 Credits)

Required MD1521: Cellular Manufacturing I


Semester 1 | Credits: 10

The production of cellular therapeutics, a defining technology of the next century, presents a unique, complex challenge combining expertise in biology, engineering, regulatory oversight and quality assurance. This course aims to instil a fundamental, working knowledge of tissue procurement, cellular expansion and biobanking, advances in bioreactor technology and good manufacturing practice. The overall scope of the module is broad, ranging from the fundamental biology of mammalian cell culture to engineering advancements leading to automated biomanufacturing of clinical therapies with constant emphasis on the production of advanced medicinal products. The principals gained from participating in this course provide an overall reference for the biomanufacturing process underpinning the production of cellular therapeutics. This module is a pre-requisite for Cellular Biomanufacturing II.
(Language of instruction: English)

Learning Outcomes
  1. Apply fundamental knowledge of therapeutic tissue procurement and cellular isolation, expansion and cryopreservation to biomanufacturing a clinical therapeutic.
  2. Recognize and evaluate advancements in bioreactor technology, strategic scale-up technologies and process design to improve biomanufacturing processes.
  3. Identify, interpret and utilize good manufacturing practice policies to produce a cellular therapy.
  4. Extrapolate foundational knowledge of adult human cellular biomanufacturing to additional applications of therapeutic manufacturing.
Assessments
  • Continuous Assessment (80%)
  • Oral, Audio Visual or Practical Assessment (20%)
Teachers
The above information outlines module MD1521: "Cellular Manufacturing I" and is valid from 2017 onwards.
Note: Module offerings and details may be subject to change.

Required MD1522: Cellular Immunotherapy


Semester 1 | Credits: 10

Adoptive cell therapy (ACT) offers the chance to utilize a patient’s own immune cells to effectively recognize and eliminate cancer cells. The most effective modality of ACT employs genetically modified chimeric antigen receptor expressing T cells (CAR T) to target surface proteins overexpressed on cancer cells. This strategy is unique from other forms of ACT, as target recognition is not MHC restricted. CAR T cells have demonstrated significant clinical potency in the treatment of certain leukemias, and trials targeting solid tumour indications are now commencing. The module is designed to deliver the current theory, practices and future perspectives in regard to collection, expansion, modification and clinical application of cancer immune cell therapy, specifically, but not limited to T cells. The following topics will be presented: history of CAR T development, strategies for effective gene delivery, cell production platforms and processes, initial clinical results associated toxicities and clinical management, challenges associated with targeting solid tumour antigens, novel CAR designs and technologies. The module will include also introduction to haematopoietic stem cell transplantation.
(Language of instruction: English)

Learning Outcomes
  1. Demonstrate in depth knowledge of basic immunology and types and sources of immune cell
  2. Present practical knowledge of heamatopoietic stem cell transplantation
  3. Demonstrate understanding of immune cell collection and expansion methods
  4. Demonstrate knowledge of methods of cell isolation, characterization and banking
  5. Evaluation of safety and efficacy specific to immune cellular products
  6. Discuss and practically implement the use of CAR T cell technology in the design of cellular immune therapeutics
  7. Critical review of current and future therapeutics applications of CAR technology in malignant disorders
Assessments
  • Continuous Assessment (55%)
  • Oral, Audio Visual or Practical Assessment (15%)
  • Department-based Assessment (30%)
Teachers
Reading List
  1. "Developments in T Cell Based Cancer Immunotherapies" by Paolo A. Ascierto
The above information outlines module MD1522: "Cellular Immunotherapy" and is valid from 2017 onwards.
Note: Module offerings and details may be subject to change.

Required MD1523: Cellular Manufacturing and Therapy Dissertation


15 months long | Credits: 30

The aim of this module is for students to A) gain relevant working experience within the field of cellular manufacturing and therapy or B) evaluate and critically assess the state of the art of specialized areas of cellular biomanufacturing and therapy. If the student is entering into a 4 month work experience programme, they will be expected to present a description of the organization, outline their role/contribution to their department and discuss how their placement is contributing to the advancement of the field of cellular manufacturing and therapy. Alternatively, students have the option to create a literature-based review of an area relevant to cellular manufacturing and therapy where they will be instructed in technical writing, the peer review process as well as oral and written presentation skills.
(Language of instruction: English)

Learning Outcomes
  1. Present a comprehensive review of 1) a research organization or company advancing the state of the art in cellular manufacturing and therapy or 2) assessing the published state of the art in a specialized area of cellular biomanufacturing and therapy.
  2. Discuss, present and defend their 1) contribution to an organization during a 4 month work placement or 2) literature review and critical analysis.
  3. Demonstrate competence and professionalism in oral and written communications.
Assessments
  • Continuous Assessment (100%)
Teachers
The above information outlines module MD1523: "Cellular Manufacturing and Therapy Dissertation" and is valid from 2018 onwards.
Note: Module offerings and details may be subject to change.

Required MD1524: Cellular Manufacturing II


Semester 2 | Credits: 10

In Cellular Manufacturing II students will be learning about the complexity of translation of practical knowledge acquired in module I into patient deliverable therapy. The module will cover the complex regulatory environment and national and international requirements. The management of cellular manufacturing facility, including operation management, staffing, planning, scheduling, budgeting, quality and role of master file will be included. This module will also deliver on key aspects of clinical trials design, trial approval and Good Clinical Practice requirements. The modules I and II should prepare a student to take on relevant roles in cell manufacturing organisations.
(Language of instruction: English)

Learning Outcomes
  1. Discuss the regulations and guidelines for cell isolation, freezing, thawing and administration of cellular products
  2. Recognise key aspects of National, European and International regulatory affairs.
  3. Describe key aspects of planning, costing of goods, operations management, health systems and policy (reimbursement)
  4. Design of GCP-compliant preclinical studies
  5. Design of bioprocesses for autologous/allogeneic therapies
  6. Perform risk-based assessment of GMP-compliant processes for the production of cell-based therapies.
  7. Discuss compliance and accreditation procedure for quality assurance standards (JACIE and others).
Assessments
  • Continuous Assessment (55%)
  • Oral, Audio Visual or Practical Assessment (15%)
  • Department-based Assessment (30%)
Teachers
Reading List
  1. "Cell Therapy: cGMP Facilities and Manufacturing" by Adrian Gee
    Publisher: SPRINGER
  2. "Guide to Cell Therapy GxP: Quality Standards in the Development of Cell-Based Medicines in Non-pharmaceutical Environments" by J. Vives
  3. "Advances In Pharmaceutical Cell Therapy: Principles Of Cell-Based Biopharmaceuticals" by R. Huss,
  4. "Cell Therapy : cGMP Facilities and Manufacturing" by Adrian Gee
    Publisher: Springer
  5. "WHO good manufacturing practices for sterile pharmaceutical products" by World Health Organisation, Annex 6
The above information outlines module MD1524: "Cellular Manufacturing II" and is valid from 2017 onwards.
Note: Module offerings and details may be subject to change.

Required MD1525: Induced Plurpotent Stem Cells


Semester 2 | Credits: 10

The Induced Pluripotent Stem Cell module is aimed to provide theoretical and practical background of the fast developing field of iPS cell research and at giving participants practical experience in derivation of induced pluripotent stem cell lines, maintenance in the culture, cell characterisation, expansion of iPS cells and differentiation into neuronal, cardiac and other tissues. The module will provide current knowledge of key scientific discoveries leading to development of reprogramming protocols and iPS technology. During the lectures, the ethics of iPS research and therapies, role of iPS in disease modelling, regeneration and therapy of hereditary (neurodegenerative and others) and acquired (heart failure, diabetes, cancer) disorders will also be discussed.
(Language of instruction: English)

Learning Outcomes
  1. Describe the process of cell reprogramming.
  2. Understand the critical steps in iPSC differentiation into different cells.
  3. Provide a global view on the current and future clinical and research applications of IPS cells.
  4. Discuss ethical aspects of iPS research and clinical applications.
Assessments
  • Continuous Assessment (55%)
  • Oral, Audio Visual or Practical Assessment (15%)
  • Department-based Assessment (30%)
Teachers
Reading List
  1. "Induced Pluripotent Stem (iPS) Cells: Methods and Protocols (Methods in Molecular Biology)" by n/a
    ISBN: 1493930540.
The above information outlines module MD1525: "Induced Plurpotent Stem Cells " and is valid from 2017 onwards.
Note: Module offerings and details may be subject to change.

Required MD1526: Mesenchymal Stromal Cell Therapy


Semester 2 | Credits: 10

The successful application of mesenchymal stromal cells (MSCs) as an advanced medicinal product is reliant upon selecting the appropriate cell source and its therapeutic mechanism of action complimenting the intended application. This course aims to instil a fundamental, working knowledge of cellular procurement, the ethical concerns surrounding advanced medicinal product development and application, the ongoing application of MSCs in clinical trials and the next generation of cellular therapeutics. The overall scope of the module is broad, ranging from the fundamental biology of mesenchymal stromal cells and their therapeutic applications to evaluating recent advancements in MSC preclinical trials to develop the next therapy. Included are hands on, laboratory-based skills including cell culture. The principals gained from participating in this course provide an overall reference for the evaluation of current literature to identify an appropriate cell source, to comprehend its mechanism of action and create a path to examine its pre-clinical efficacy in support of a regulatory submission.
(Language of instruction: English)

Learning Outcomes
  1. Compare and contrast the qualities of progenitor cells from various tissue sources in relation to their intended application.
  2. Demonstrate practical competence in mesenchymal stromal culture expansion and cryopreservation.
  3. Evaluation of the current literature regarding the safety and efficacy of mesenchymal stromal cells in pre-clinical and clinical applications.
  4. Acquire a basic understanding of the key Good Manufacturing Practices (GMP) that are required in the manufacture (expansion) of stem cells.
Assessments
  • Continuous Assessment (60%)
  • Oral, Audio Visual or Practical Assessment (40%)
Teachers
The above information outlines module MD1526: "Mesenchymal Stromal Cell Therapy" and is valid from 2017 onwards.
Note: Module offerings and details may be subject to change.

Optional IE446: Project Management


Semester 1 | Credits: 5

Project management is a means to an end and not an end in itself. The purpose of project management is to foresee or predict as many of the potential pitfalls and problems as soon as possible and to plan, organise and control activities so that the project is successfully completed in spite of any difficulties and risks. This process starts before any resources are committed, and must continue until all the work is completed. The primary aim of this course is to improve the effectiveness of people engaged in project management. It focuses on the essential concepts and practical skills required for managing projects in dynamic environments. This course aims to provide learners with a solid understanding of the fundamentals of project management and to equip them with simple yet powerful tools that will empower them to meet their full potential in the area of project management thus enabling them to implement successful projects on time, within budget and to the highest possible standard.
(Language of instruction: English)

Learning Outcomes
  1. Understand the critical influencing factors for successful project management and execution.
  2. Understand the key reasons for failure and to comprehend the impact and implications of project failure on the individual, team and organisation.
  3. Specify an effective project plan, which is consistent with the business plan of the company
  4. Demonstrate the ultimate success of the plan through successful project implementation
  5. Be capable of using appropriate tools to schedule a project and associated activities and tasks
  6. Be capable of using tools to analyse the health of a project portfolio and to select relevant projects that align with the overall portfolio.
  7. Understand the concept of cross functional team working
  8. Gain a solid grounding in transferable skills such as problem specification, team working, and the ability to synthesise and apply acquired knowledge to the solution of problems
Assessments
  • Continuous Assessment (100%)
Teachers
Reading List
  1. "Project Management: A Managerial Approach" by Meredith, J.R. and Mantel, S.J.
  2. "A Guide to the Project Management Body of Knowledge (PMBOK® Guide)" by Project Management Institute
The above information outlines module IE446: "Project Management" and is valid from 2017 onwards.
Note: Module offerings and details may be subject to change.

Optional BI460: Molecular and Cellular Biology of Cancer


Semester 1 | Credits: 10

The module aims to give students the opportunity to gain in depth and advanced understanding of the causes of tumour formation and the molecular mechanism behind cancer development (tumourigenesis) in line with the current state of the art. Through the module, the students can attain a comprehensive understanding of the molecular and cellular processes relevant to tumour development, growth and survival, including the processes that lead to genetic instability, drive tumour growth, cause resistance to therapeutics or help the tumour cells to escape from detection by the immune system.
(Language of instruction: English)

Learning Outcomes
  1. Describe the mechanism and steps of tumour formation and understand the difference between the processes that drive the development vs. survival of a tumour
  2. Discuss the signal transduction pathways and molecular processes that drive tumour formation, growth and survival
  3. Analyse how aberrations in a molecular pathway may influence tumour development/growth
  4. Source and analyse information from the literature and relay the gained knowledge to their peers through a seminar presentation
Assessments
  • Continuous Assessment (20%)
  • Department-based Assessment (80%)
Teachers
The above information outlines module BI460: "Molecular and Cellular Biology of Cancer" and is valid from 2017 onwards.
Note: Module offerings and details may be subject to change.

Optional EC584: Economic Evaluation in Health Care


Semester 1 | Credits: 10

The module examines the theory and practice of economic evaluation as it applies to health and social care interventions. Topics covered include the rationale for economic evaluation; formulating a health evaluation problem; identifying and measuring outcomes and effectiveness; identifying, enumerating, and valuing the inputs to form an economic measure of costs; measuring the benefits of health interventions using contingent valuation and discrete choice experiments
(Language of instruction: English)

Learning Outcomes
  1. Understand the variety of economic evaluation techniques used to evaluate health interventions
  2. Critically assess the different theoretical rationales for health interventions
  3. Understand the different ways for measuring and valuing costs
  4. Understand the various methods for measuring outcomes in cost effectiveness and cost utility analysis
  5. Critically assess the advantages and disadvantages of QALYs
  6. Understand the use of contingent valuation in health economics
  7. Understand the use of experimental techniques to measure the value of interventions in health care
  8. Conduct a literature search and review of CEA and CUA studies in a particular health intervention
Assessments
  • Written Assessment (100%)
Teachers
Reading List
  1. "Methods for the Economic Evaluation of Health Care Programmes" by Drummond, Michael F. et al.
    Publisher: Oxford University Press
  2. "Applied Methods of Cost-effectiveness Analysis in Health Care" by Alastair Gray et al.
    Publisher: Oxford University Press
  3. "Applied Methods of Cost-Benefit Analysis in Health Care" by McIntosh, Emma et al.
    Publisher: Oxford University Press
  4. "The Elgar Companion to Health Economics" by Jones, Andrew M. et al.
    Publisher: Edmund Elgar
The above information outlines module EC584: "Economic Evaluation in Health Care" and is valid from 2018 onwards.
Note: Module offerings and details may be subject to change.

Optional PM208: Fundamental Concepts in Pharmacology


Semester 1 | Credits: 5

This module introduces students to fundamental pharmacological concepts of pharmacodynamics and pharmacokinetics. A combination of lectures, tutorials and workshops will be used.

Learning Outcomes
  1. describe the main drug targets
  2. interpret dose response curves for agonists, antagonists, inverse agonists
  3. calculate molarities, concentrations, volumes required in making solutions
  4. access and critically analyse and interpret pharmacological data
  5. describe the processes of absorption, distribution, metabolism and excretion for specific drugs
  6. explain the effects of different routes of administration on absorption of drugs, and effects of food and drug interactions on drug disposition
  7. derive pharmacokinetic data and use them to predict clinical properties of drugs
Assessments
  • Continuous Assessment (30%)
  • Computer-based Assessment (70%)
Teachers
Reading List
  1. "Pharmacology" by Rang, H.P., Dale, Ritter, Flower & Henderson
    Publisher: Churchill Livingstone
  2. "Principles of Pharmacology" by Golan, D.E., et al
  3. "Lippincott’s Illustrated Reviews Pharmacology" by Harvey, R.A.
The above information outlines module PM208: "Fundamental Concepts in Pharmacology" and is valid from 2016 onwards.
Note: Module offerings and details may be subject to change.

Optional MG529: Introduction To Business


Semester 1 | Credits: 10

Assessments
  • Continuous Assessment (100%)
Teachers
The above information outlines module MG529: "Introduction To Business" and is valid from 2014 onwards.
Note: Module offerings and details may be subject to change.

Optional MD1528: First in Human, Early Phase Clinical Trials


Semester 1 | Credits: 10

This course will introduce researchers to the fundamental elements necessary to conduct First in Man, Early Phase Research in adherence to Good Clinical Practice guidelines using didactic and practical teaching, experiential learning ,inquiry-based and a cooperative learning approach. Researchers will be guided though the meaning of early phase research, study design, safety and clinical oversight, statistical considerations, emergency training, biological specimen management and clinical site preparation with the objective to enable researchers conduct early phase research to standards that surpass audit and inspection requirement.
(Language of instruction: English)

Learning Outcomes
  1. Understand and describe the process of translating novel drug/ device from the bench to the bedside
  2. Draft essential documents necessary for the conduct of phase 1 FIM Clinical Trials
  3. Describe dose escalation and dose expansion
  4. define and differentiate pharmacokinetics and pharmacodynamics and the implications of biological specimen management
  5. Identify challenges of conducting phase 1 trials and methods to overcome these
  6. demonstrate an in-depth knowledge of measures to ensure patient safety which includes safety event clinical management, data capture and reporting, Data Safety Monitoring Board Coordination, Investigator Brochure and Data Safety Update Reporting
Assessments
  • Continuous Assessment (85%)
  • Oral, Audio Visual or Practical Assessment (15%)
Teachers
The above information outlines module MD1528: "First in Human, Early Phase Clinical Trials" and is valid from 2018 onwards.
Note: Module offerings and details may be subject to change.

Optional BME511: Tissue Engineering


Semester 2 | Credits: 5

This course integrates the principles and methods if engineering and life sciences towards the fundamental understanding if structure-function relationships in normal and pathological mammalian tissues especially as they relate to the development of biological tissues to restore, maintain, or improve tissue/organ function.
(Language of instruction: English)

Learning Outcomes
  1. Specify the different types of biodegradable biomaterials that can be used in tissue engineering applications.
  2. Discuss the complex interactions between biomaterials, cells and signals in biological systems.
  3. Demonstrate awareness in contemporary topics such as gene therapy, stem cells, proteonomics, genomics and bioreactors.
  4. Demonstrate their capability in conducting a multidisciplinary project.
Assessments
  • Continuous Assessment (100%)
Teachers
The above information outlines module BME511: "Tissue Engineering" and is valid from 2015 onwards.
Note: Module offerings and details may be subject to change.

Why Choose This Course?

Career Opportunities

At NUI Galway, we are uniquely positioned to draw on existing expertise in science education, biomedical research, Good Manufacturing Practice (GMP)-grade cellular manufacturing and clinical translation of advanced therapeutics to educate future leaders in these emerging technologies.  

Graduates will be well positioned for careers in advanced medicinal therapy development or the manufacturing of ATMPs.

 

 

 

 

 

 

Who’s Suited to This Course

Learning Outcomes

 

Work Placement

Study Abroad

Related Student Organisations

Course Fees

Fees: EU

€8,500 p.a. 2018/19

Fees: Tuition

€8,276 p.a. 2018/19

Fees: Student levy

€224 p.a. 2018/19

Fees: Non EU

€17,000 p.a. 2018/19

 

 

 

 

 

 

 

Find out More

Cynthia Coleman
T: +353 91 495852
E: cynthia.coleman@nuigalway.ie

Janusz Krawczyk
E: janusz.krawczyk@nuigalway.ie

 

 

 

 

 

 

 

Andrew

Andrew Finnerty |   General Manager, Centre for Cell Manufacturing Ireland

The MSc in Cellular Manufacturing and Therapy at NUI Galway is a wonderful programme providing graduates with the professional skills they require for employment in the research, development, translation and manufacturing of novel advanced therapeutic products. In particular, this course provides the laboratory-based skills and training in the practical techniques required for GMP-manufacturing of cell products. It delivers a solid scientific rationale underpinning the development of cellular therapies; the very skills and knowledge that I require in future employees.
in Connect with Andrew
Richa

Richa Krishna |   MSc student, Cellular Manufacturing & Therapy

Hailing from a clinical background and being aware of its current traditional therapy limitations, I opted for Cellular Manufacturing & Therapy to explore the future of advanced cell therapy. This field has a lot of potential due to current clinical trials and research advances. This course gave me an opportunity to gain knowledge of the state of the art of the cellular therapies transitioning into the health care systems around the globe. If this area interests you, NUIG would lend you a perfect platform from where you can shape your career in the research field or industry. Needless to add Galway is very friendly place for international students with support to help along your academic journey.
Rory

Rory Rafferty |   MSc student, Cellular Manufacturing & Therapy

I chose this course because after spending 3 years working in the medical device industry I knew that I needed a chance in scenery. The reputation of NUIG as one of the colleges at the forefront of research, clinical trials, cellular manufacturing and GMP in the field of regenerative medicines naturally attracted me to the course. I felt that it was the perfect stepping stone that would allow me to greatly improve my CV. I feel the course has given me invaluable transferable skills. It has also given me a true insight into the workings of clinical research and Good Manufacturing Practices that I feel will allow me to leave my own lasting mark in the scientific world.
in Connect with Rory
Ti

Ti Zhang |   MSc student, Cellular Manufacturing & Therapy

A one-year taught master programme, Cellular Manufacturing & Therapy focuses on translating innovative biological therapies to clinical applications, especially in the stem cell area. This course has a close relationship with the Regenerative Medicine Institute scientists and Centre for Cellular Manufacturing Ireland staff. Participating in this course will significantly improve your academic performance and capability in the laboratory. Our extremely friendly lecturers will bring engaging classroom activities and the small class size includes students from different backgrounds, makes learning approachable.
James

James O'Brien |   MSc student, Cellular Manufacturing & Therapy

During my Biotechnology undergraduate degree, I was generally most interested in the modern medical aspects, especially regenerative medicine, gene therapy and cell therapy. Unsurprisingly, when I heard that this new MSc. program was being set up, I immediately made inquiries, and found myself excited about applying. So far, this course has given me enormous insight into the scientific background of modern cellular therapies and has also provided practical industrial skills and knowledge. The course is well-structured, and the co-ordinators and lecturers have vast experience and excellent portfolios in the field. I feel my overall skillset has been specialized abundantly in just a short time by this course, and I feel like I will be more confident when applying for industrial jobs in the cellular therapy domain.